Summary

Enter the vibrant world of the North American ventilator industry and discover the throbbing heart of inventiveness in healthcare. This sector becomes a key player in a world where technology and empathy coexist, changing the parameters of respiratory support and critical care. With its diverse range of innovations, North America serves as a forge where innovative ventilator technologies are developed with the goal of sustaining life throughout the most critical junctures in human history. The North American Ventilator Industry is a monument to human tenacity and the unwavering pursuit of development, from the research labs buzzing with the sound of scientific investigation to the production plants where cutting-edge equipment turns ideas into real lifelines. This is not just a business; it's a lifeline, a complex web where knowledge and compassion join together to create breath-guarding gadgets that represent the unshakable devotion to human health with each breath in and breathe out. The main drivers propelling the growth of this market in North America are the rising rates of acute lung injury, hypoxemia, and sleep apnea, as well as other respiratory illnesses such as chronic obstructive pulmonary disease (COPD). The elderly population's quick expansion and the rise in preterm births are both predicted to hasten the market's overall growth. In addition, the high rate of tobacco use, which causes respiratory illnesses, will support the market's expansion. Prominent players in the North American Ventilator Market have been continuously innovating, introducing features such as advanced monitoring capabilities, improved patient interfaces, and enhanced portability. The market has also witnessed collaborations between technology companies and healthcare providers to integrate artificial intelligence and data analytics into ventilator systems, aiming to optimise patient outcomes and streamline healthcare processes.

According to the research report "North America Ventilator Market Outlook, 2028," published by Bonafide Research, the North America Ventilator market is anticipated to add USD 900 Million from 2023 to 2028. In North America, respiratory conditions such as lung cancer, acute lower respiratory tract infections, asthma, TB, and chronic obstructive pulmonary disease (COPD) are among the most frequent causes of severe illness and mortality. A number of significant variables contributing to the growth in occurrences of respiratory and cardiovascular illness include urbanisation, increased pollution, bad lifestyle choices, and a high incidence of tobacco use. Mechanical ventilation is necessary for the treatment of this condition since it might induce abrupt respiratory failure. 2020 saw the diagnosis of COPD in about 14 million individuals in the United States, according to the Office of Disease Prevention and Health Promotion. Furthermore, the Centres for Disease Control and Prevention (CDC) estimated that more than 23 million Americans had asthma in 2018. Furthermore, individuals with asthma reported more than a million ED visits and above 180,000 hospital stays throughout the nation in 2017. Furthermore, a ventilator helps patients with respiratory illnesses and other breathing abnormalities, which can make breathing difficult or impossible. Therefore, as respiratory disorders become more common, there is a greater need for ventilators, which is driving the expansion of the ventilator market in North America. There is a growing trend towards home-based care for chronic respiratory patients. Homecare ventilation allows patients to receive respiratory support in the comfort of their homes, reducing hospital stays and healthcare costs. The demand for portable and user-friendly ventilators suitable for homecare settings is expected to drive market growth.

The North American Ventilator market is segmented into the United States, Canada, and Mexico. The United States held the largest share of the North American ventilator market in 2022. The United States possesses one of the most advanced and sophisticated healthcare systems globally. Its extensive network of healthcare facilities, research institutions, and medical professionals creates a conducive environment for the development, manufacturing, and utilisation of advanced medical technologies, including ventilators. The U.S. is home to a robust and innovative medical technology industry. Major companies in the healthcare sector, including well-established manufacturers and startups, are based in the U.S. These entities contribute significantly to the development and production of cutting-edge ventilator technologies. The government and private sector allocate substantial resources to research and development in the healthcare industry. This investment fosters innovation, supports the creation of new technologies, and accelerates the introduction of advanced ventilator systems to the market. History of mobilising resources swiftly in response to public health emergencies. During events such as the COVID-19 pandemic, the U.S. government took proactive measures to address the increased demand for ventilators, including facilitating regulatory approvals, incentivizing production, and coordinating public-private partnerships.

Based on the mobility types, they are segmented into the Instruments/Ventilator Machines and Portable/transportable Ventilators. Among them, in North America, the Instruments/Ventilator Machines lead the ventilator market. Regions with a strong focus on research and development in the medical field are likely to produce innovative and advanced medical devices, including ventilators. North America, particularly the United States, has a robust healthcare and medical research ecosystem with significant investments in R&D. The demand for medical equipment, including ventilators, is influenced by factors such as population size, healthcare infrastructure, and the prevalence of respiratory diseases. If there is a high demand for ventilators in North America due to a large population or a higher incidence of respiratory conditions, it could contribute to the region's leadership in the market. The economic strength of a region can also impact its ability to invest in and adopt advanced medical technologies. Wealthier regions may have more resources to allocate to healthcare and medical equipment. The healthcare system in North America is characterised by a mix of public and private providers. The emphasis on providing high-quality medical care and the presence of leading healthcare institutions contribute to the culture of using state-of-the-art medical equipment, including ventilators.

In terms of the types, there are adult/pediatric ventilators and Neonata/infant ventilators among them in North America. Neonata/Infant Ventilators are growing at the highest rate. Ongoing advancements in medical technology have led to the development of more sophisticated and specialised neonatal and infant ventilators. These innovations often include features tailored to the unique respiratory needs of newborns and infants, improving their overall care and outcomes. There is growing recognition of respiratory issues in neonates and infants, leading to an increased demand for ventilators. Premature birth, congenital abnormalities, and respiratory distress syndrome are among the factors that can contribute to respiratory challenges in newborns, necessitating the use of ventilatory support. There has been a heightened focus on neonatal care and paediatrics within the healthcare system. Advances in neonatology and paediatric medicine have emphasised the importance of specialised equipment, including ventilators, to address the unique needs of this patient population. Increased awareness and education among healthcare professionals, as well as the general public, about the importance of specialised care for newborns and infants can contribute to a higher demand for neonatal and infant ventilators. This awareness may drive hospitals and healthcare facilities to invest in advanced equipment to improve outcomes for these vulnerable patients.

According to the report, the end users are segmented into hospitals, home healthcare, ambulatory surgical centres, and others. Among them in North America, ambulatory surgical centres are growing and will have the second highest market share in 2022. The trend of shifting certain surgical procedures from traditional hospitals to ambulatory surgical centres has been observed in North America. ASCs are designed to provide same-day surgical care, and as they expand their scope of services, the need for advanced medical equipment, including ventilators, increases. Ambulatory surgical centres are increasingly equipped to handle more complex and specialised surgical procedures that require post-operative respiratory support. Ventilators are crucial in providing respiratory assistance to patients recovering from anaesthesia or undergoing procedures that impact respiratory function. Ambulatory surgical centres prioritise patient safety and comfort. Adequate respiratory support during and after surgical procedures is essential for patient well-being. Ventilators play a role in ensuring that patients can recover safely and comfortably in the post-anaesthesia care unit (PACU) within the ambulatory setting.

Based on the indications, they are segmented into cardiovascular disorders and hypertension, cancer, respiratory diseases, diabetes, movement disorders, wound care, pregnancy, hearing disorders, and other indications. Among them, in North America, cardiovascular disorders and hypertension will lead the market with the largest market share in 2022. Cardiovascular disorders, including coronary artery disease, heart failure, and stroke, are among the leading causes of death in North America. These conditions often lead to respiratory failure, requiring mechanical ventilation to support breathing. Hypertension, also known as high blood pressure, is a major risk factor for cardiovascular diseases and can also contribute to respiratory complications. North America's population is ageing, and older adults are more likely to develop cardiovascular diseases and hypertension. This demographic shift contributes to the increasing demand for ventilators in the region. Public health initiatives and awareness campaigns have increased the recognition and treatment of cardiovascular disorders and hypertension. This has led to earlier diagnosis and management of these conditions, potentially reducing the need for ventilator support in some cases.

Companies Covered in this report:

Koninklijke Philips N.V., ResMed Inc. , Getinge AB, Drägerwerk AG & Co. KGaA, Medtronic plc , Nihon Kohden Corporation, Air Liquide S.A., GE HealthCare Technologies, Inc., Fisher & Paykel Healthcare Corporation Limited , Hill-Rom Holdings, Inc.

Considered in this report:

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• North America Ventilator market Outlook with its value and forecast along with its segments
• Country-wise Ventilator market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Mobility

• Instruments/ Ventilator Machines
• Portable/transportable Ventilators

By End User

• Hospitals
• Ambulatory Surgical Centers
• Home Healthcare
• Others

By Types:

• Adult/Pediatric Ventilators
• Neonata/Infant Ventilators

By Indication

• Cardiovascular Disorders & Hypertension
• Cancer
• Respiratory Diseases
• Diabetes
• Movement Disorders
• Wound Care
• Pregnancy
• Hearing Disorders
• Other Indications

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Ventilator industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.





***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents